Anticoagulation application of nafamostat mesylate in patients on continuous renal replacement therapy at a high risk of hemorrhage
ObjectiveTo explore the efficacy and safety of nafamostat mesylate (NM) in patients on continuous renal replacement therapy (CRRT) at a high risk of hemorrhage.MethodsFrom March 2021 to February 2022, a retrospective study was conducted for 61 CRRT patients at a high risk of hemorrhage in intensive...
Sábháilte in:
| Príomhchruthaitheoirí: | , , , , , |
|---|---|
| Formáid: | LEABHAR |
| Foilsithe / Cruthaithe: |
Editorial Department of Journal of Clinical Nephrology,
2024-02-01T00:00:00Z.
|
| Ábhair: | |
| Rochtain ar líne: | Connect to this object online. |
| Clibeanna: |
Cuir clib leis
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|
Ar líne
Connect to this object online.3rd Floor Main Library
| Gairmuimhir: |
A1234.567 |
|---|---|
| Cóip 1 | Ar fáil |